Related references
Note: Only part of the references are listed.From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology Modeling in Cancer Immunotherapy
Vincent Lemaire et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)
Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics
Rahul Khetan et al.
MABS (2022)
Navigating Between Right, Wrong, and Relevant: The Use of Mathematical Modeling in Preclinical Decision Making
Anna Kondic et al.
FRONTIERS IN PHARMACOLOGY (2022)
Separating clinical antibodies from repertoire antibodies, a path to in silico developability assessment
Christopher Negron et al.
MABS (2022)
Early Feasibility Assessment: A Method for Accurately Predicting Biotherapeutic Dosing to Inform Early Drug Discovery Decisions
Diana H. Marcantonio et al.
FRONTIERS IN PHARMACOLOGY (2022)
Novel SIRPα Antibodies That Induce Single-Agent Phagocytosis of Tumor Cells while Preserving T Cells
Gabriela Andrejeva et al.
JOURNAL OF IMMUNOLOGY (2021)
Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding
Robyn J. Puro et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges
Huixi Zou et al.
FRONTIERS IN PHARMACOLOGY (2020)
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
Branimir Sikic et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Structure, heterogeneity and developability assessment of therapeutic antibodies
Yingda Xu et al.
MABS (2019)
Bispecific T-cell engagers: Towards understanding variables influencing the in vitro potency and tumor selectivity and their modulation to enhance their efficacy and safety
Diego Ellerman
METHODS (2019)
Linear pharmacokinetic parameters for monoclonal antibodies are similar within a species and across different pharmacological targets: A comparison between human, cynomolgus monkey and hFcRn Tg32 transgenic mouse using a population-modeling approach
Alison Betts et al.
MABS (2018)
Advances in absolute protein quantification and quantitative protein mapping using ICP-MS
Laura Cid-Barrio et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2018)
CD47-ligation induced cell death in T-acute lymphoblastic leukemia
Pascal Leclair et al.
CELL DEATH & DISEASE (2018)
A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE (R)) antibody construct, in patients with refractory solid tumors
Maxim Kebenko et al.
ONCOIMMUNOLOGY (2018)
Quantitative Flow Cytometry: Concerns and Recommendations in Clinic and Research
Olga Mizrahi et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2018)
Optimal Affinity of a Monoclonal Antibody: Guiding Principles Using Mechanistic Modeling
Abhinav Tiwari et al.
AAPS JOURNAL (2017)
Systems pharmacology and enhanced pharmacodynamic models for understanding antibody-based drug action and toxicity
Sihem Ait-Oudhia et al.
MABS (2017)
A mechanistic PK/PD model for two anti-IL13 antibodies explains the difference in total IL-13 accumulation observed in clinical studies
Abhinav Tiwari et al.
MABS (2016)
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Ron Sender et al.
PLOS BIOLOGY (2016)
Developability Assessment During the Selection of Novel Therapeutic Antibodies
Alexander Jarasch et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
CD47 Agonist Peptides Induce Programmed Cell Death in Refractory Chronic Lymphocytic Leukemia B Cells via PLCγ1 Activation: Evidence from Mice and Humans
Ana-Carolina Martinez-Torres et al.
PLOS MEDICINE (2015)
Quantitative Prediction of Human Pharmacokinetics for mAbs Exhibiting Target-Mediated Disposition
Aman P. Singh et al.
AAPS JOURNAL (2015)
Target Antigen Density Governs the Efficacy of Anti-CD20-CD28-CD3 ζ Chimeric Antigen Receptor-Modified Effector CD8+ T Cells
Keisuke Watanabe et al.
JOURNAL OF IMMUNOLOGY (2015)
A Multiscale Model of Interleukin-6-Mediated Immune Regulation in Crohn's Disease and Its Application in Drug Discovery and Development
G. Dwivedi et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)
Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer
Elena Garcia-Martinez et al.
BREAST CANCER RESEARCH (2014)
An estimation of the number of cells in the human body
Eva Bianconi et al.
ANNALS OF HUMAN BIOLOGY (2013)
Issues, Challenges, and Opportunities in Model-Based Drug Development for Monoclonal Antibodies
Leijun Hu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Epithelium percentage estimation facilitates epithelial quantitative protein measurement in tissue specimens
Jing Chen et al.
CLINICAL PROTEOMICS (2013)
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B. Willingham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
From Target Selection to the Minimum Acceptable Biological Effect Level for Human Study: Use of Mechanism-based PK/PD Modeling to Design Safe and Efficacious Biologics
Jing Yu et al.
AAPS JOURNAL (2011)
Quantitative Prediction of Human Pharmacokinetics for Monoclonal Antibodies Retrospective Analysis of Monkey as a Single Species for First-in-Human Prediction
Jennifer Q. Dong et al.
CLINICAL PHARMACOKINETICS (2011)
Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data What have we learned?
Rong Deng et al.
MABS (2011)
Properties of a general PK/PD model of antibody-ligand interactions for therapeutic antibodies that bind to soluble endogenous targets
Jasmine P. Davda et al.
MABS (2010)
Does the cell number 109 still really fit one gram of tumor tissue?
Ugo Del Monte
CELL CYCLE (2009)
Developability Assessment in Pharmaceutical Industry: An Integrated Group Approach for Selecting Developable Candidates
Vishal Saxena et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Mass Spectrometry Based Targeted Protein Quantification: Methods and Applications
Sheng Pan et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM
Markus Munz et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research
Meindert Danhof et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
The role of mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modelling in translational research of biologics
Balaji M. Agoram et al.
DRUG DISCOVERY TODAY (2007)
MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors
K Brischwein et al.
MOLECULAR IMMUNOLOGY (2006)
Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) family
G Brooke et al.
JOURNAL OF IMMUNOLOGY (2004)
Is a raised intraepithelial lymphocyte count with normal duodenal villous architecture clinically relevant?
S Mahadeva et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
On the dynamics of TCR:CD3 complex cell surface expression and downmodulation
HY Liu et al.
IMMUNITY (2000)
Share Paper
